NEW YORK, NY / ACCESSWIRE / November 10, 2017 / U.S. markets record rally stalled on Thursday on concerns of a delay in President Trump's proposed tax plan. The Dow Jones Industrial Average declined 0.43 percent to close at 23,461.94, while the S&P 500 Index fell 0.38 percent to close at 2,584.62. The Nasdaq Composite Index dropped 0.58 percent to close at 6,750.05. The new tax plan would see the corporate tax rate slashed from 35 percent to 20 percent. A newly proposed plan by the Senate would delay the tax cut until 2019.

"A combination of worries about the tax delay and news about Department of Justice's stance on the AT&T deal sparked a mild risk-off day," said Kate Warne, investment strategist at Edward Jones, according to MarketWatch.

"It's a sign that regulatory regime is not quite as favorable as investors first thought, while delays to tax reform means slower growth next year," Warne added.

RDI Initiates Coverage on:

Endo International plc
https://rdinvesting.com/news/?ticker=ENDP

Immunomedics, Inc.
https://rdinvesting.com/news/?ticker=IMMU

Endo International plc's stock had no change Thursday, to close the day at $6.09. The stock recorded a trading volume of 9,964,158 shares, which was above its three months average volume of 6,713,900 shares. In the last year, Endo International plc's shares have traded in a range of 5.77 - 18.63. The stock is currently trading 67.31% below its 52 week high. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $7.71 is below its 200-day moving average of $10.02. Shares of Endo International have fallen roughly 28.35 percent in the past month and are down 63.02 percent year-to-date.

Access RDI's Endo International plc Research Report at:
https://rdinvesting.com/news/?ticker=ENDP

On Thursday, shares in Immunomedics, Inc. recorded a trading volume of 2,747,124 shares, which was below the three months average volume of 2,838,180 shares. The stock ended the day 3.06% higher at 10.44. The share price has gained 344.26% from its 52-week low with a 52-week trading range of 2.35 - 14.48.The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $11.68 is greater than its 200-day moving average of $9.34. Shares of Immunomedics have fallen roughly 15.87 percent in the past month and are up 184.47 percent year-to-date.

Access RDI's Immunomedics, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=IMMU

Our Actionable Research on Endo International plc (NASDAQ:ENDP) and Immunomedics, Inc. (NASDAQ:IMMU) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com